Entry of big firms in healthcare space will benefit users: PharmEasy's Siddharth Shah
API Holdings' Siddharth Shah on whats next for Thyrocare after the PharmEasy deal, APIs existing online drug delivery business, and what he makes of deep-pocketed rivals Reliance and Tata Group. Excerpts from the interview: